On May 6, 2026, the Eagle Analytical team met with the Louisianna Board of Pharmacy to support pharmaceutical clients by pioneering the implementation of ScanRDI® testing in sterile compounding.
Eagle values transparency and collaboration- foundational features underlying analytical testing.
We prioritize clients and provide tools to conserve patient safety. Eagle’s mission focuses on clarity- elucidating innovative transitions & science-based technology, navigating pressing discussions, and characterizing data-driven protocols reflecting operational needs- the epitome of advocacy.
We aim to continue aseptic services for pharmacies & healthcare enterprises through scientific guidance, regulatory compliance, and industry-related advocacy.
Eagle is committed in pursuit of the extra mile- our client’s trust in us is a responsibility we take seriously. We remain dedicated to protecting it through quality, transparency, & service.
